Contravir Pharmaceut (CTRV) Stock Analyst Ratings
NASDAQ:CTRV - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to CTRV. The Buy consensus is the weighted average rating of the current analysts ratings.
CTRV was analyzed by 1 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about CTRV.
In the previous month the buy percentage consensus was at a similar level.
Only 1 analysts analyzed CTRV. So this is just the average opinion of a couple of analysts.